230 related articles for article (PubMed ID: 31799188)
1. Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer.
Wujanto C; Vellayappan B; Siva S; Louie AV; Guckenberger M; Slotman BJ; Onishi H; Nagata Y; Liu M; Lo SS
Front Oncol; 2019; 9():1219. PubMed ID: 31799188
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions.
Dunne EM; Fraser IM; Liu M
Ann Transl Med; 2018 Jul; 6(14):283. PubMed ID: 30105233
[TBL] [Abstract][Full Text] [Related]
3. Role of radiation in oligometastases and oligoprogression in metastatic non-small cell lung cancer: consensus and controversy.
Kumar A; Salama JK
Expert Rev Respir Med; 2023; 17(11):1033-1040. PubMed ID: 37962878
[TBL] [Abstract][Full Text] [Related]
4. Oligometastatic Disease (OMD): The Classification and Practical Review of Prospective Trials.
Izmailov T; Ryzhkin S; Borshchev G; Boichuk S
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958408
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiotherapy for early lung cancer: Evidence-based approach and future directions.
Chehade S; Palma DA
Rep Pract Oncol Radiother; 2015; 20(6):403-10. PubMed ID: 26696779
[TBL] [Abstract][Full Text] [Related]
6. Oligometastatic Disease Management: Finding the Sweet Spot.
Szturz P; Nevens D; Vermorken JB
Front Oncol; 2020; 10():617793. PubMed ID: 33415080
[TBL] [Abstract][Full Text] [Related]
7. The Yin and Yang of Cytoreductive SBRT in Oligometastases and Beyond.
Onderdonk BE; Chmura SJ
Front Oncol; 2019; 9():706. PubMed ID: 31428580
[No Abstract] [Full Text] [Related]
8. Stereotactic Body Radiotherapy for Patients with Lung Oligometastatic Disease: A Five-Year Systematic Review.
Virbel G; Le Fèvre C; Noël G; Antoni D
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298836
[TBL] [Abstract][Full Text] [Related]
9. Metastasectomy and Stereotactic Body Radiotherapy for Colorectal Cancer With Liver and Lung Oligometastases: A Case Report of Complete Remission in a 96-Year-Old Patient.
Pan M
Cureus; 2024 Apr; 16(4):e58135. PubMed ID: 38741816
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck Tumours.
Tham JLM; Ng SP; Khor R; Wada M; Gan H; Thai AA; Corry J; Bahig H; Mäkitie AA; Nuyts S; De Bree R; Strojan P; Ng WT; Eisbruch A; Chow JCH; Ferlito A
J Clin Med; 2024 May; 13(11):. PubMed ID: 38892731
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body proton therapy for non-small cell lung cancer: Clinical indications and recommendations.
McMillan MT; Kang M; Shepherd AF; Liu W; Lin L; Lin H; Simone CB
J Radiosurg SBRT; 2023; 9(1):17-32. PubMed ID: 38029014
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy for liver metastases in oligometastatic disease.
Jaksic N; Modesto A; Meillan N; Bordron A; Michalet M; Riou O; Lisbona A; Huguet F
Cancer Radiother; 2024 Feb; 28(1):75-82. PubMed ID: 37865603
[TBL] [Abstract][Full Text] [Related]
13. Multimodality Treatment of Advanced Non-small Cell Lung Cancer: Where are we with the Evidence?
Jones CM; Brunelli A; Callister ME; Franks KN
Curr Surg Rep; 2018; 6(2):5. PubMed ID: 29456881
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy for bone oligometastases.
Naessens C; Chamois J; Supiot S; Faivre JC; Arnaud A; Thureau S
Cancer Radiother; 2024 Feb; 28(1):111-118. PubMed ID: 37838605
[TBL] [Abstract][Full Text] [Related]
15. Liver metastases and SBRT: A new paradigm?
Comito T; Clerici E; Tozzi A; D'Agostino G
Rep Pract Oncol Radiother; 2015; 20(6):464-71. PubMed ID: 26696787
[TBL] [Abstract][Full Text] [Related]
16. Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond?
Ng SSW; Ning MS; Lee P; McMahon RA; Siva S; Chuong MD
Adv Radiat Oncol; 2020; 5(4):761-773. PubMed ID: 32775790
[TBL] [Abstract][Full Text] [Related]
17. Surgical approach in the oligometastatic patient.
Divisi D; Barone M; Zaccagna G; Gabriele F; Crisci R
Ann Transl Med; 2018 Mar; 6(5):94. PubMed ID: 29666817
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Treatment Strategy for Oligometastases/Oligo-Recurrence of Colorectal Cancer.
Yokoi R; Tajima JY; Fukada M; Hayashi H; Kuno M; Asai R; Sato Y; Yasufuku I; Kiyama S; Tanaka Y; Murase K; Matsuhashi N
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201569
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Potential Predictive Biomarkers for Defining Brain Radiotherapy Efficacy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Case Report and a Narrative Review.
Luciano A; Liguori L; Polcaro G; Sabbatino F; Pepe S
Clin Pract; 2023 Nov; 13(6):1549-1560. PubMed ID: 38131685
[TBL] [Abstract][Full Text] [Related]
20. Does Radiotherapy Have Curative Potential in Metastatic Patients? The Concept of Local Therapy in Oligometastatic Breast Cancer.
Dellas K
Breast Care (Basel); 2011 Oct; 6(5):363-368. PubMed ID: 22619646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
